Reference

1. James A Church,Felicity Fitzgerald,A Sarah walker,etal.The expanding role of co-trimoxazole in developing countries.vol 15,21 january 2015,page no 327, DOI:https://doi.org/10.1016/S1473-3099(14)71011-4
2. E.goldberg and J bishara.contemporary unconvectional clinical use of co-trimoxazole.vol 18 issue on January 2012,page no 8,https://doi.org/10.1111/j.1469-0691.2011.03613.x.
3. Robert H Rubin,M.D,And Morton N Swartz,M.D.the new England journal of medicine,medical intelligence.vol 303,August 21,1980,Page no 426,Doi:10.1056/NEJM198008213030804
4. Roth B, Falco EA,Hitchings GH, Bushby SR. 5-Benzyl-2,4-diaminopyrimidines as antibacterial agent . I. Synthesises and antibacterial activity in vitro. Vol 5,November 1962 page no 1104,https://doi.org/10.1021/jm01241a004
5. Juan Carlos palomino and Aanandi Martin.the potential role of trimethoprim-sulfamethoxazole in the treatment of drug-resistant tuberculosis .vol 11,No.4,12 April 2016,page no 2 ,https://doi.org/10.2217/fmb.16.2
6. Leon G.Smith,M.D,and John sensakotic,M.D.Symposium on antimicrobial therapy.vol 66,January 1982,page no 144-145,150.https://doi.org/10.1016/S0025-7125(16)31448-1
7. Mark kester PhD,Kelly D karpa,Kent E Verna PhD.teatment of infectious diseases,page no 61-62,https;//doi.org/10.1016/B978-0-323-07445-2.00004-5
8. Claudia ganero,Ariana Zoppi,Diego Genovese,etal.Studies on trimethoprim:hydroxypropyl-?-cyclodextrin:aggregate and complex formation.vol 345,22 November 2010,pages no 2550, doi:10.1016/j.carres.2010.08.018
9. zinner SH,Mayer KH.Basic principles in the diagnosis and management of infectious diseases : Sulponamides and trimethoprim.In: Mandell GL,Douglas RG,Bennett JE,principles and practices of infectious diseases.4th edition Edinburg: Churchill livingstone,1996:354
10. Umer Rashid, Waqas  Ahamad, Sayed Fahad Hassan, etal. Design, synthesis, antibacterial activity and docking study of some new trimethoprim derivatives.vol 26,1 December 2016,page no 5749, http://dx.doi.org/10.1016/j.bmcl.2016.10.051.
11. R.S Vardanyan,V.J Hruby.synthesis of essential drugs, issued on 2006,page no 510,511. https://doi.org/10.1016/B978-044452166-8/50033-9
12. Shahnaz Rostamizadeh, Zahra Daneshfar,Hamid Moghimi. Synthesis of sulfamethoxazole and sulfabenzamide metal complexes; evaluation of their antibacterial activity.vol 171,1 june 2019,page no 365. https://doi.org/10.1016/j.ejmech.2019.03.002
13. Anurag K. Singh, Ashok K. Sharma, Iliyas Khan. oral drug delivery potential of dendrimers.issue 2017,page no 252, https://doi.org/10.1016/B978-0-323-47720-8.00010-9
14. Jill E Maddison, A David J Watson and Jonathan Elliot.principles of antibacterial therapy.issued 2008,page no 178-179. https://doi.org/10.1016/B978-070202858-8.50010-5
15. Eric Scholar University of Nebraska Medical Center, Omaha, USA.sulfamethoxazole.issue on 2007,page no 1,2. https://doi.org/10.1016/B978-008055232-3.62693-5
16. Suman Rohilla, Deepika Sharma. A Comprehensive Resource of Anti-Infective and Anti-cancer Drugs. issue on 2023,page no 21-63. https://doi.org/10.1016/B978-0-323-90575-6.00015-6
17. .Mark Kester PhD,Kelly D Karpa PhD,Kent E.Vrana PhD.treatment of infectious diseases.issue on 2012,page no 21,DOI: https://doi.org/10.1016/B978-0-323-07445-2.00004-5
18. Y?lmaz Karaca, Nilay Coplu , Aysegul Gozalan,etal. Co-trimoxazole and quinolone resistance in Escherichia coli isolated from urinary tract infections over the last 10 years.vol 26,issue on 1 july 2005,page no 75,DOI: https://doi.org/10.1016/j.ijantimicag.2005.03.012
19. Jasmine BL Lee, Guy H Neild. Obstruction and infection, Urinary tract infection.vol 35,issue on 8 August 2007,page no 425,426.DOI: https://doi.org/10.1016/j.mpmed.2007.05.009
20. Jean M. Smellie ~, Reuben N. Griineberg 2, Helen M. Bantock ,etal. Prophylactic co-trimoxazole and trimethoprim in the management of urinary tract infection in children. Issue on March 1988,page No 12-13,DOI: https://doi.org/10.1007/BF00870372
21. Walter L Straus, Shamim A Qazi, Zafarullah Kundi,etal. Antimicrobial resistance and clinical effectiveness of co-trimoxazole versus amoxycillin for pneumonia among children in Pakistan: randomised controlled trial.vol 352,issue on July 25 1998,Page No 270-273,DOI: https://doi.org/10.1016/S0140-6736(97)10294-X
22. Coen a. Stegeman, m.d., jan willem cohen tervaert, m.d., paul e,etal. Trimethoprim–sulfamethoxazole (co-trimoxazole) for the prevention of relapses of wegener’s granulomatosis.vol 335,issue on 4 July 1996,page no 16-19,DOI: 10.1056/NEJM199607043350103
23. Alexander Rozin, Daniel Schapira, Yolanda Braun-Moscovici,etal. Cotrimoxazole Treatment for Rheumatoid Arthritis,vol  31,issue on October 2001,133-134,DOI: https://doi.org/10.1053/sarh.2001.27734
24. Ramam M, Garg T, D’Souza P etal. A two-step schedule for the treatment of actinomycotic mycetomas. Vol  80,issue on 2000,Page no 378-380.DOI: https://doi.org/10.1080/000155500459367
25. Larka UB, Ulett D, Garrison T, Rockett MS. Aeromonas hydrophila infections after penetrating foot trauma. Vol 42 issue on sep-oct 2003,page no 305,DOI: https://doi.org/10.1016/S1067-2516(03)00305-3
26. Legrand C, Anaissie E. Bacteremia due to Achromobacter xylosoxidans in patients with cancer,vol 14,issue on 2 feb 1992,page no 479-484,DOI: https://doi.org/10.1093/clinids/14.2.479
27. Al-Jasser AM. Stenotrophomonas maltophilia resistant to trimethoprim– sulfamethoxazole: an increasing problem.issue on 2006,page no 23-25,DOI: https://doi.org/10.1186/1476-0711-5-23
28. Roushan MR, Gangi SM, Ahmadi SA. Comparison of the efficacy of two months of treatment with co-trimoxazole plus doxycycline vs. co-trimoxazole plus rifampin in brucellosis.vol 134, Issue 18 September 2004,page no 564-568,
29. Genton B, Mueller I, Betuela I et al. Rifampicin/cotrimoxazole/isoniazid versus mefloquine or quinine + sulfadoxine–pyrimethamine for malaria: a randomized trial.issue on 2006,Page no 38,DOI: https://doi.org/10.1371/journal.pctr.0010038
30. Fung KT, Dhillon AP, McLaughlin JE et al. Cure of Acanthamoeba cerebral abscess in a liver transplant patient.Vol 14,issue on March 2008,Page no 308-312,DOI: https://doi.org/10.1002/lt.21409
31. Omar SA, Bakari A, Owiti A, Adagu IS, Warhurst DC. Co-trimoxazole compared with sulfadoxine–pyrimethamine in the treatment of uncomplicated malaria in Kenyan children.Vol 95,issue on Nov-Dec 2001,page no 657-660.DOI: https://doi.org/10.1016/S0035-9203(01)90107-5
32. Verdier RI, Fitzgerald DW, Johnson WD Jr, etal. Trimethoprim– sulfamethoxazole compared with ciprofloxacin for treatment and prophylaxis of Isospora belli and Cyclospora cayetanensis infection in HIV-infected patients. A randomized, controlled trial. Volume 132, Issue 11, 6 June 2000, Pages 885-888,DOI: https://doi.org/10.7326/0003-4819-132-11-200006060-00006.